From the Editor: Notable and Noteworthy

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel medicines for patients living with rare diseases including Lambert-Eaton myasthenic syndrome, congenital myasthenic syndromes, MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL."

Catalyst Pharmaceuticals Company Stats
Industry
Drugs & Biotechnology
Founded
2002
Headquarters
Coral Gables, Florida
Country/Territory
United States
CEO
Patrick J. McEnany
Employees
82

Catalyst Pharmaceuticals Financial Summary

Select list year
2023
2022
2021
Revenue
$302.9M
Sources
FactSet; Forbes.
Catalyst Pharmaceuticals (CPRX) Stock Price Performance
Catalyst Pharmaceuticals (CPRX) Stock Key Data
SummaryAdditional DataAnalystsHistorical Quotes
Related People & Companies
Pharma Prod Devel
Pharma Prod Devel
Related by Industry: Drugs & Biotechnology
View Profile
Alcon
Alcon
Related by Industry: Drugs & Biotechnology
View Profile
Miami, FL
Miami, FL
Located in Miami-Miami Beach-Kendall, FL Metropolitan Division Metropolitan Area
View Profile

More on Forbes